Abeona Therapeutics Inc
F:PCJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abeona Therapeutics Inc
F:PCJ
|
US |
|
Spie SA
F:4SP
|
FR |
|
Urban Edge Properties
F:3UE
|
US |
|
E
|
Eco Wave Power Global AB (publ)
NASDAQ:WAVE
|
SE |
|
A
|
Alphabet Inc
NASDAQ:GOOG
|
US |
|
C
|
China Merchants Port Holdings Co Ltd
XMUN:CPM
|
HK |
|
AdvanSix Inc
F:960
|
US |
|
M
|
Marsh & McLennan Companies Inc
SWB:MSN
|
US |
|
E
|
Edwards Lifesciences Corp
F:EWL
|
US |
|
Kering SA
F:PPXB
|
FR |
|
S
|
Sea Ltd
F:931
|
SG |
|
B
|
Boston Scientific Corp
XMUN:BSX
|
US |
|
F
|
First Citizens BancShares Inc (Delaware)
F:FC6A
|
US |
Wall St Price Targets
PCJ Price Targets Summary
Abeona Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for PCJ is 16.715 EUR with a low forecast of 10.994 EUR and a high forecast of 24.616 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PCJ's stock price target?
Price Target
16.715
EUR
According to Wall Street analysts, the average 1-year price target for PCJ is 16.715 EUR with a low forecast of 10.994 EUR and a high forecast of 24.616 EUR.
What is the Revenue forecast for Abeona Therapeutics Inc?
Projected CAGR
71%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 71%.
What is the Net Income forecast for Abeona Therapeutics Inc?
Projected CAGR
16%
The compound annual growth rate for Net Income over the next 8 years is 16%.
